Ricevi le ultime notizie sulle azioni MaxCyte con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di MXCT

Ultime notizie per

MaxCyte

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

MaxCyte Inc

Earnings

Press Releases

MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance

MaxCyte and Ori Biotech Collaborate to Improve Manufacturing Efficiencies and Broaden Adoption of Autologous Cellular Therapies

News

MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025

Health Care

MaxCyte Announces Strategic Platform Licensing Agreement with Anocca AB to Advance TCR-T Cell Therapy Pipeline

MaxCyte Signs Platform License Agreement with Adicet Bio

MaxCyte Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Guidance

Biotech Movers: Four Companies Making Big Strides in Innovation and Growth (MDCX, ARQT, CRMD, MCXT)

MaxCyte Announces Operational Restructuring to Reduce Costs and Accelerate Path to Profitability

General

MaxCyte Announces Strategic Platform License Agreement with Moonlight Bio to Advance T Cell Therapies for Solid Tumors

MaxCyte to Report Third Quarter 2025 Financial Results on November 5, 2025

ARQT

CRMD

MDCX

MXCT

Atlantic International Corp. - Common Stock

Atlantic International

Applied DNA Sciences, Inc. - Common Stock

Applied DNA Sciences

Bionano Genomics

CDT Equity

Codexis

Champions Oncology

Cytek Biosciences

CryoPort

Harvard Bioscience

MindWalk Holdings

Standard BioTools

Lifecore Biomedical

Mesa Laboratories

Maravai LifeSciences Holdings, Inc. - Class A common stock

Maravai LifeSciences

Nautilus Biotechnology, Inc. - Common Stock

Nautilus Biotechnology

Inotiv

OmniAb

Pacific Biosciences of California, Inc. - Common Stock

Pacific Biosciences

Quantum-Si Incorporated - Class A Common Stock

Quantum-Si

Quanterix

Rapid Micro Biosystems, Inc. - Class A Common Stock

Rapid Micro Biosystems

Seer

Alpha Teknova

Stephens & Co.

Stifel

Craig-Hallum

Comments

MaxCyte Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO